GLP-1 Medications

    Tirzepatide Weight Loss Medication

    The highest average weight loss of any GLP-1, with a team that tracks every pound. Tirzepatide activates two hormone receptors to reduce appetite and improve how your body processes food.

    Tirzepatide Medication
    20-22%
    Average body weight lost in clinical trials
    1x
    Weekly injection takes under a minute
    Monthly
    Check-ins with dosage adjustments

    How it Works

    How Tirzepatide Works

    Tirzepatide is a dual-action medication that targets two hormone receptors: GLP-1 and GIP. Most weight loss medications in this class activate only GLP-1. By engaging both receptors, tirzepatide reduces appetite, slows digestion, and improves how your body regulates blood sugar and stores fat.

    Dual-Action Mechanism

    Targets two key hormones (GLP-1 and GIP) for superior weight loss results.

    Enhanced Weight Loss

    Clinically proven to produce greater results than single-hormone medications.

    Sustained Appetite Control

    Helps you feel full with smaller portions by addressing biological signals.

    Typical Results

    What Results Look Like

    Clinical trials showed participants lost an average of 20% to 22.5% of their body weight over 72 weeks.

    2w

    Weeks 2–4

    Reduced appetite and smaller portion sizes become noticeable.

    8w

    Weeks 8–12

    Measurable weight loss appears on the scale.

    16w

    Month 4–6

    Therapeutic dose reached; weight loss accelerates.

    72w

    72 Weeks

    Average 20-22.5% body weight lost in clinical trials.

    Eligibility

    Who Qualifies

    Confirm your candidacy through a health history review at your first appointment.

    BMI of 30 or higher (obesity classification)
    BMI of 27 or higher with a weight-related condition
    No personal or family history of medullary thyroid cancer
    Not currently pregnant or planning pregnancy
    Schedule a Consultation

    Common Side Effects

    Most side effects are gastrointestinal and tend to resolve as your body adjusts.

    • Nausea (most common during first weeks)
    • Diarrhea or constipation
    • Reduced appetite
    • Occasional stomach pain or indigestion

    How We Manage Side Effects

    Elite begins every patient at 2.5 mg weekly and increases the dose gradually over several months to balance results with tolerability.

    Your Program

    What to Expect at Elite

    01

    Titration and Dosing Schedule

    Starts at 2.5 mg weekly. Increases in 2.5 mg increments every four weeks, typically taking 4-5 months to reach maintenance.

    02

    Monthly Monitoring

    Monthly visits include weigh-ins, vital signs, and dosage adjustments based on progress and side effects.

    Common Questions

    Frequently Asked Questions

    Experience the Elite Difference

    Schedule your consultation today to see if tirzepatide is the right fit for your weight loss goals.

    Book Your Consultation